UniGene: Dr.118653
Protein FAM26E (UniProt: A4FUN9) is a protein expressed in Danio rerio (zebrafish) with a complete amino acid sequence of 310 residues. This protein belongs to the FAM26 family of proteins and is encoded by the fam26e gene (also known as zgc:136947) . Zebrafish serve as excellent model organisms for studying gene function due to their genetic similarity to humans, transparent embryos, high fecundity, and rapid development. Research into FAM26E helps understand its conservation across species, potential roles in developmental processes, and contributions to physiological functions in vertebrates.
The protein's amino acid sequence begins with MDSFKTVLKFFTDQKT and contains multiple transmembrane domains, suggesting potential roles in cellular communication or transport functions . Zebrafish are increasingly used as models for toxicology studies, making FAM26E potentially important for understanding gene-environment interactions.
Recombinant FAM26E protein from zebrafish is typically produced using eukaryotic expression systems to ensure proper protein folding and post-translational modifications. While bacterial expression systems (E. coli) offer cost-effective production, they often struggle with proper folding of complex eukaryotic proteins. For FAM26E, yeast expression systems provide an excellent balance between production efficiency and proper protein conformation.
The production typically involves:
Gene cloning: The fam26e gene sequence is amplified from zebrafish cDNA and inserted into an appropriate expression vector containing a His-tag for purification.
Expression: The construct is transformed into the host organism (yeast being particularly effective for zebrafish proteins). As noted in comparable protein expression methods, "The yeast protein expression system is the most economical and efficient eukaryotic system for secretion and intracellular expression" .
Purification: The protein is typically purified using affinity chromatography (utilizing the His-tag), followed by size exclusion chromatography to achieve >90% purity .
Quality control: Verification of protein identity using mass spectrometry and functional testing via appropriate assays.
The resulting recombinant protein is typically stored in a Tris-based buffer with 50% glycerol to maintain stability .
Optimal storage conditions for recombinant FAM26E protein are crucial for maintaining its structural integrity and biological activity. Based on standard protocols for similar zebrafish recombinant proteins, the following storage conditions are recommended:
Long-term storage: -20°C or -80°C in a Tris-based buffer containing 50% glycerol .
Working aliquots: Store at 4°C for up to one week to minimize freeze-thaw cycles .
Avoid repeated freeze-thaw cycles as this can lead to protein denaturation and loss of activity .
When handling the protein:
Thaw frozen aliquots on ice
Mix gently by inversion rather than vortexing
Work with pre-chilled pipettes and tubes
Return to appropriate storage conditions immediately after use
The lyophilized form of the protein (if available) provides extended shelf-life and should be reconstituted according to manufacturer recommendations immediately before use .
Detection of FAM26E expression patterns in zebrafish tissues requires multiple complementary techniques to ensure reliable results:
RT-qPCR: For quantitative analysis of fam26e mRNA expression:
Extract RNA from specific tissues or developmental stages
Perform reverse transcription followed by quantitative PCR with fam26e-specific primers
Normalize to appropriate reference genes (e.g., ef1α, β-actin)
In situ hybridization: For spatial visualization of expression:
Generate antisense RNA probes against fam26e mRNA
Perform whole-mount in situ hybridization for embryos or section-based in situ for adult tissues
Include sense probes as negative controls
Immunohistochemistry: For protein-level detection:
Use validated antibodies against FAM26E (validate specificity with recombinant protein)
Perform on tissue sections or whole-mount for embryos
Include appropriate blocking and secondary antibody controls
Western blotting: For protein quantification:
Extract proteins from target tissues
Separate by SDS-PAGE and transfer to membrane
Probe with validated anti-FAM26E antibodies
This multi-modal approach provides comprehensive information about both transcriptional and translational expression patterns across tissues and developmental stages.
Studying gene-environment interactions (GxE) involving FAM26E requires careful experimental design using the genetic diversity of zebrafish populations. Based on established methodologies in zebrafish research, the following approach is recommended:
Establish genetically diverse zebrafish populations:
Design exposure experiments:
Measure behavioral and morphological outcomes:
Quantify FAM26E expression changes:
Perform RT-qPCR or RNA-Seq to measure fam26e expression changes across treatments and genetic backgrounds
Correlate expression changes with behavioral or morphological phenotypes
Statistical analysis to detect GxE effects:
This comprehensive approach allows researchers to determine if genetic background influences FAM26E-mediated responses to environmental exposures.
Investigating protein-protein interactions involving FAM26E requires multiple complementary approaches to build a reliable interaction network:
Yeast two-hybrid (Y2H) screening:
Use FAM26E as bait against zebrafish cDNA libraries
Validate positive interactions with targeted Y2H assays
Consider membrane-specific Y2H systems given FAM26E's predicted transmembrane domains
Co-immunoprecipitation (Co-IP) with recombinant FAM26E:
Perform pull-down assays using His-tagged recombinant FAM26E
Identify binding partners by mass spectrometry
Validate interactions with reciprocal Co-IP experiments
Proximity-dependent biotin identification (BioID):
Generate FAM26E-BioID fusion constructs for expression in zebrafish cells
Identify proteins that are biotinylated due to proximity to FAM26E
Validate with other interaction methods
Bimolecular Fluorescence Complementation (BiFC):
Create fusion constructs of FAM26E and potential partners with split fluorescent protein fragments
Express in zebrafish embryos or cell culture
Visualize interactions through fluorescence microscopy
Surface Plasmon Resonance (SPR):
This multi-method approach provides robust evidence for protein interactions while minimizing false positives inherent to any single method.
CRISPR-Cas9 genome editing provides powerful tools for FAM26E functional studies in zebrafish. Here's an optimized methodology:
gRNA design for FAM26E targeting:
Design multiple gRNAs targeting different exons using zebrafish-specific tools
Prioritize sites with minimal predicted off-target effects
Consider targeting functional domains based on sequence analysis
Check for restriction sites near the cut site for genotyping purposes
Delivery method optimization:
Microinject Cas9 protein (not mRNA) with gRNAs into one-cell stage embryos
Standardize injection volumes and concentrations
Include phenol red in injection mix for visualization
Use tracrRNA:crRNA complexes for improved editing efficiency
Validation of editing efficiency:
Design PCR primers flanking the target site
Perform T7 Endonuclease I assay on pooled embryos at 24 hpf
Sequence PCR products from individual embryos to characterize mutations
Quantify mosaicism levels in F0 founders
Generation of stable lines:
Raise F0 mosaic fish to adulthood
Outcross to wild-type and screen F1 offspring for germline transmission
Sequence to identify carriers of frameshift mutations
Establish homozygous lines through F1 incrossing
Phenotypic characterization:
This comprehensive approach ensures reliable gene editing while minimizing off-target effects and providing thorough functional characterization.
Transcriptomic analysis provides valuable insights into FAM26E-related pathways and functions. Based on successful approaches in zebrafish research, the following methodology is recommended:
Experimental design:
Compare wild-type, FAM26E knockdown, and FAM26E overexpression models
Include multiple biological replicates (minimum n=3 per condition)
Consider tissue-specific and temporal factors in sampling
Integrate environmental exposures to identify GxE effects
RNA isolation and quality control:
Extract RNA using TRIzol or RNeasy kits
Verify RNA integrity via Bioanalyzer (RIN > 8)
Quantify RNA concentration via fluorometric methods
Prepare separate pools for biological replicates
Library preparation and sequencing:
Prepare stranded mRNA libraries
Aim for 20-30 million paired-end reads per sample
Include spike-in controls for normalization
Sequence across multiple lanes to avoid batch effects
Data analysis pipeline:
Quality control with FastQC
Alignment to zebrafish genome (GRCz11)
Quantification using tools like featureCounts or Salmon
Differential expression analysis using DESeq2 or edgeR
Functional analysis:
This approach enables comprehensive characterization of transcriptional changes associated with FAM26E function, particularly in response to environmental factors.
Optimizing ELISA assays with recombinant FAM26E protein requires systematic parameter adjustments and careful validation:
Assay design selection:
Direct ELISA: Immobilize FAM26E protein directly on the plate
Sandwich ELISA: Use capture and detection antibodies specific to different FAM26E epitopes
Competitive ELISA: Best for measuring FAM26E in complex biological samples
Critical optimization parameters:
Coating buffer optimization (carbonate buffer pH 9.6 vs. PBS pH 7.4)
Blocking agent selection (BSA, milk, commercial blockers)
Antibody dilution optimization using checkerboard titration
Sample dilution determination
Incubation time and temperature optimization
Validation protocol:
Determine linear range using purified recombinant FAM26E
Calculate limit of detection (LoD) and limit of quantification (LoQ)
Assess inter- and intra-assay coefficient of variation (CV < 15%)
Perform spike-recovery experiments in sample matrix
Test for cross-reactivity with related proteins
Specialized considerations for FAM26E:
Following this systematic approach ensures development of a reliable, sensitive, and specific ELISA for FAM26E quantification in research applications.
Rigorous controls and validation methods are essential for reliable FAM26E expression studies:
Essential experimental controls:
Positive control: Tissues known to express FAM26E (based on preliminary data)
Negative control: Tissues with minimal FAM26E expression
Technical controls: No-template controls for PCR, secondary-antibody-only controls for immunoassays
Knockout/knockdown controls: Samples with verified FAM26E inhibition
Validation across multiple methods:
Transcript level: RT-qPCR with multiple primer sets targeting different exons
Protein level: Western blot with antibodies targeting different epitopes
Localization: In situ hybridization and immunohistochemistry
Cross-validation: Compare results across all methods
Antibody validation framework:
Pre-absorption control: Pre-incubate antibody with recombinant FAM26E protein
Specificity testing: Verify single band of expected size via Western blot
Knockout validation: Confirm signal loss in FAM26E knockout/knockdown samples
Cross-reactivity assessment: Test against closely related proteins
RNA interference validation:
Use multiple siRNA/morpholino sequences targeting different regions
Include scrambled sequences as negative controls
Verify knockdown efficiency via RT-qPCR and Western blot
Perform rescue experiments with recombinant protein
This comprehensive validation approach ensures reliable and reproducible FAM26E expression data while minimizing artifacts and false results.
Assessing FAM26E's functional impact on zebrafish development requires a multi-faceted approach combining genetic manipulation with phenotypic analysis:
Temporal expression profiling:
Perform RT-qPCR analysis of fam26e expression at key developmental stages (6, 24, 48, 72, 96, 120 hpf)
Conduct whole-mount in situ hybridization to map spatial expression patterns
Correlate expression with critical developmental milestones
Loss-of-function approaches:
Generate CRISPR-Cas9 knockout lines
Design antisense morpholinos targeting translation start site or splice junctions
Validate knockdown efficiency at protein level via Western blot
Comprehensive phenotypic assessment:
Morphological screening: Assess standard endpoints at 24 hpf and 120 hpf as described in zebrafish toxicology studies
Behavioral analysis: Conduct standardized tests like the larval photomotor response assay
Tissue-specific assessment: Examine development of specific organs based on expression patterns
Gain-of-function approaches:
Microinject FAM26E mRNA at one-cell stage
Create transgenic lines with tissue-specific FAM26E overexpression
Administer recombinant FAM26E protein (if cell-permeable or receptor-mediated)
Gene-environment interaction studies:
This systematic approach provides comprehensive insights into FAM26E's developmental functions while establishing causal relationships between gene function and phenotypic outcomes.
Post-translational modifications (PTMs) of FAM26E can significantly influence its function and localization. The following methodological approaches are recommended:
Computational prediction of potential PTMs:
Use bioinformatic tools to predict potential phosphorylation, glycosylation, and other modification sites
Compare predictions across species for evolutionary conservation
Prioritize sites with high prediction scores or conservation
Mass spectrometry-based identification:
Immunoprecipitate FAM26E from zebrafish tissues or cell lysates
Perform tryptic digestion followed by LC-MS/MS analysis
Use both collision-induced dissociation (CID) and electron-transfer dissociation (ETD) fragmentation
Apply enrichment strategies for specific modifications (e.g., TiO₂ for phosphopeptides)
Site-directed mutagenesis validation:
Generate FAM26E constructs with mutations at predicted PTM sites
Express in zebrafish embryos or cell culture
Compare localization, stability, and function with wild-type protein
PTM-specific antibodies:
Generate or source antibodies against specific FAM26E modifications
Validate specificity using appropriate controls
Apply in Western blot and immunohistochemistry
Modification dynamics:
Study changes in PTM patterns during development
Investigate effects of environmental stressors on modification status
Compare PTM patterns across different tissues
This comprehensive approach enables detailed characterization of FAM26E post-translational modifications and their functional significance in zebrafish development and physiology.
Recombinant FAM26E protein can be leveraged for multiple protein interaction screening approaches:
Protein microarray screening:
Pull-down assays with immobilized FAM26E:
Surface Plasmon Resonance (SPR) screening:
Immobilize FAM26E on sensor chips
Flow candidate interacting proteins over the surface
Measure binding kinetics and affinity constants
Perform competition assays to identify binding sites
AlphaScreen/AlphaLISA assays:
Couple FAM26E to donor beads and potential partners to acceptor beads
Measure proximity-induced signal upon interaction
Screen libraries of candidate proteins
Optimize buffer conditions to reduce false positives
Crosslinking-Mass Spectrometry (XL-MS):
Incubate recombinant FAM26E with potential binding partners
Apply chemical crosslinkers to stabilize interactions
Digest and analyze by mass spectrometry
Identify interaction interfaces through crosslinked peptides
These complementary approaches provide a comprehensive strategy for identifying and characterizing FAM26E protein interactions, which is crucial for understanding its biological functions.
Behavioral assays provide powerful phenotypic readouts for characterizing FAM26E function in zebrafish. The larval photomotor response (LPR) assay is particularly valuable:
Standardized LPR protocol:
Equipment: Zebrabox behavioral analysis chambers (ViewPoint Behavior Technologies)
Age: 120 hours post fertilization (hpf)
Assay duration: 24 minutes total
Light conditions: 4 cycles of 3 minutes light followed by 3 minutes dark
Data collection: Movement tracking with motion analysis software
Behavioral phenotyping advantages:
Non-invasive assessment
High-throughput capability
Sensitive to subtle neurological phenotypes
Quantifiable using standardized metrics
Allows for population-level genetic analysis
Data analysis approach:
Application to FAM26E studies:
Compare behavioral profiles between FAM26E knockdown/knockout and controls
Assess if FAM26E modification alters response to environmental stressors
Determine if genetic background influences FAM26E-related behavioral phenotypes